Boston Scientific lands another date with FDA panel for Watchman stroke device

An FDA advisory panel is slated to convene yet again in October to consider the safety and efficacy of Boston Scientific's Watchman anti-stroke heart repair device.

Boston Scientific, Food & Drug Administration (FDA)

News Well, Cardiac Implants, Pre-Market Approval (PMA), Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1qo8rD5